Adding Saxagliptin to Metformin Extended Release (XR) or Uptitration of Metformin XR: Efficacy on Daily Glucose Measures

por Neutel, Joel M., Zhao, Cathy, Karyekar, Chetan S.
Publicado 2013

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus

por Karyekar, Chetan S, Ravichandran, Shoba, Allen, Elsie, Fleming, Douglas, Frederich, Robert
Publicado 2013

The multifaceted impact of anxiety and depression on patients with rheumatoid arthritis

por Peterson, Steve, Piercy, James, Blackburn, Stuart, Sullivan, Emma, Karyekar, Chetan S., Li, Nan
Publicado 2019

High risk of depression, anxiety, and an unfavorable complex comorbidity profile is associated with SLE: a nationwide patient-level study

por Kósa, Fruzsina, Kunovszki, Péter, Gimesi-Országh, Judit, Kedves, Melinda, Szabó, Melinda, Karyekar, Chetan S., Nagy, György
Publicado 2022

Large-scale mortality gap between SLE and control population is associated with increased infection-related mortality in lupus

por Kedves, Melinda, Kósa, Fruzsina, Kunovszki, Péter, Takács, Péter, Szabó, Melinda Zsuzsanna, Karyekar, Chetan, Lofland, Jennifer H, Nagy, György
Publicado 2020

Update on prevalence of diagnosed systemic lupus erythematosus (SLE) by major health insurance types in the US in 2016

por Wang, Yiting, Hester, Laura L., Lofland, Jennifer, Rose, Shawn, Karyekar, Chetan S., Kern, David M., Blacketer, Margaret, Davis, Kourtney, Shields-Tuttle, Kimberly
Publicado 2022

Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, r...

por Helliwell, Philip S, Gladman, Dafna D, Chakravarty, Soumya D, Kafka, Shelly, Karyekar, Chetan S, You, Yin, Campbell, Kim, Sweet, Kristen, Kavanaugh, Arthur, Gensler, Lianne S
Publicado 2020

Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phas...

por Coates, Laura C, Gossec, Laure, Theander, Elke, Bergmans, Paul, Neuhold, Marlies, Karyekar, Chetan S, Shawi, May, Noël, Wim, Schett, Georg, McInnes, Iain B
Publicado 2022

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a...

por Emery, Paul, Burmester, Gerd R, Bykerk, Vivian P, Combe, Bernard G, Furst, Daniel E, Barré, Emilie, Karyekar, Chetan S, Wong, Dennis A, Huizinga, Tom W J
Publicado 2015

Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with ac...

por Rahman, Proton, Mease, Philip J., Helliwell, Philip S., Deodhar, Atul, Gossec, Laure, Kavanaugh, Arthur, Kollmeier, Alexa P., Hsia, Elizabeth C., Zhou, Bei, Lin, Xiwu, Shawi, May, Karyekar, Chetan S., Han, Chenglong
Publicado 2021

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis

por Mease, Philip J, McInnes, Iain B, Tam, Lai-Shan, Eaton, Kiefer, Peterson, Steve, Schubert, Agata, Chakravarty, Soumya D, Parackal, Anna, Karyekar, Chetan S, Nair, Sandhya, Boehncke, Wolf-Henning, Ritchlin, Christopher
Publicado 2021

Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, plac...

por Mease, Philip J, Gladman, Dafna D, Deodhar, Atul, McGonagle, Dennis G, Nash, Peter, Boehncke, Wolf-Henning, Gottlieb, Alice, Xu, Xie L, Xu, Stephen, Hsia, Elizabeth C, Karyekar, Chetan S, Helliwell, Philip S
Publicado 2020

Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis

por Coates, Laura C, Ritchlin, Christopher T, Gossec, Laure, Helliwell, Philip S, Rahman, Proton, Kollmeier, Alexa P, Xu, Xie L, Shawi, May, Karyekar, Chetan S, Contré, Christine, Noël, Wim, Sheng, Shihong, Wang, Yanli, Xu, Stephen, Mease, Philip J
Publicado 2022

Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort

por Ugarte-Gil, Manuel Francisco, Gamboa-Cardenas, Rocio Violeta, Reátegui-Sokolova, Cristina, Pimentel-Quiroz, Victor Román, Medina, Mariela, Elera-Fitzcarrald, Claudia, Zevallos, Francisco, Pastor-Asurza, Cesar Augusto, Zazzetti, Federico, Karyekar, Chetan S, Alarcón, Graciela S, Perich-Campos, Risto Alfredo
Publicado 2022

LLDAS (lupus low disease activity state) and/or remission are associated with less damage accrual in patients with systemic lupus erythematosus from a primarily Mestizo population:...

por Ugarte-Gil, Manuel Francisco, Gamboa-Cardenas, Rocio Violeta, Reátegui-Sokolova, Cristina, Pimentel-Quiroz, Victor Román, Medina, Mariela, Elera-Fitzcarrald, Claudia, Zevallos, Francisco, Pastor-Asurza, Cesar Augusto, Lofland, Jeniffer, Zazzetti, Federico, Karyekar, Chetan S, Alarcón, Graciela S, Perich-Campos, Risto Alfredo
Publicado 2022

Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies

por McGonagle, Dennis, McInnes, Iain B, Deodhar, Atul, Schett, Georg, Shawi, May, Kafka, Shelly, Karyekar, Chetan S, Kollmeier, Alexa P, Hsia, Elizabeth C, Xu, Xie L, Sheng, Shihong, Agarwal, Prasheen, Zhou, Bei, Ritchlin, Christopher T, Rahman, Proton, Mease, Philip J
Publicado 2021

Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study...

por Ritchlin, Christopher T, Helliwell, Philip S, Boehncke, Wolf-Henning, Soriano, Enrique R, Hsia, Elizabeth C, Kollmeier, Alexa P, Chakravarty, Soumya D, Zazzetti, Federico, Subramanian, Ramanand A, Xu, Xie L, Zuraw, Qing C, Sheng, Shihong, Jiang, Yusang, Agarwal, Prasheen, Zhou, Bei, Zhuang, Yanli, Shawi, May, Karyekar, Chetan S, Deodhar, Atul
Publicado 2021